Literature DB >> 10580081

Lipoprotein lipase, a key role in atherosclerosis?

J R Mead1, A Cryer, D P Ramji.   

Abstract

Lipoprotein lipase (LPL) plays a central role in lipid metabolism and transport by catalysing the hydrolysis of triacylglycerol-rich lipoproteins. The importance of LPL expressed by the adipose tissue and muscles in the provision of non-esterified fatty acids and 2-monoacylglycerol for tissue utilisation is well established. However, recent studies on LPL expressed by cells of the vascular wall, particularly macrophages, have identified additional actions of the enzyme that contribute to the promotion of foam cell formation and atherosclerosis. This review deals with the role of LPL in atherosclerosis, and its regulation by mediators that are known to be present in the lesion.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10580081     DOI: 10.1016/s0014-5793(99)01495-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  8 in total

Review 1.  The emergence of sedentary behaviour physiology and its effects on the cardiometabolic profile in young and older adults.

Authors:  D J Ryan; G K Stebbings; G L Onambele
Journal:  Age (Dordr)       Date:  2015-08-28

Review 2.  Emerging strategies of targeting lipoprotein lipase for metabolic and cardiovascular diseases.

Authors:  Werner J Geldenhuys; Li Lin; Altaf S Darvesh; Prabodh Sadana
Journal:  Drug Discov Today       Date:  2016-10-19       Impact factor: 7.851

Review 3.  N-3 vs. saturated fatty acids: effects on the arterial wall.

Authors:  S Sudheendran; C C Chang; R J Deckelbaum
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2010-03-06       Impact factor: 4.006

4.  Tissue-specific expression of human lipoprotein lipase in the vascular system affects vascular reactivity in transgenic mice.

Authors:  Victor E Esenabhalu; Mirza Cerimagic; Roland Malli; Karin Osibow; Sanja Levak-Frank; Maud Frieden; Wolfgang Sattler; Gerhard M Kostner; Rudolf Zechner; Wolfgang F Graier
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

Review 5.  Pharmacogenetics of glucose-lowering drug treatment: a systematic review.

Authors:  Ozlem Bozkurt; Anthonius de Boer; Diederick E Grobbee; Eibert R Heerdink; Huib Burger; Olaf H Klungel
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

6.  Role of leptin in atherogenesis.

Authors:  Laxman Dubey; Zeng Hesong
Journal:  Exp Clin Cardiol       Date:  2006

7.  Functional significance of lipoprotein lipase HindIII polymorphism associated with the risk of coronary artery disease.

Authors:  Qi Chen; Hamid Razzaghi; F Yesim Demirci; M Ilyas Kamboh
Journal:  Atherosclerosis       Date:  2008-02-01       Impact factor: 5.162

Review 8.  Dyslipidemia: Genetics, lipoprotein lipase and HindIII polymorphism.

Authors:  Marcos Palacio Rojas; Carem Prieto; Valmore Bermúdez; Carlos Garicano; Trina Núñez Nava; María Sofía Martínez; Juan Salazar; Edward Rojas; Arturo Pérez; Paulo Marca Vicuña; Natalia González Martínez; Santiago Maldonado Parra; Kyle Hoedebecke; Rosanna D'Addosio; Clímaco Cano; Joselyn Rojas
Journal:  F1000Res       Date:  2017-11-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.